| Peripheral 5-HT1D and 5-HT7 serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats JÁ García-Pedraza, M García, ML Martín, J Gómez-Escudero, ... European journal of pharmacology 714 (1-3), 65-73, 2013 | 25 | 2013 |
| Role of 5-HT7 receptors in the inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats C Cuesta, JÁ García-Pedraza, M García, CM Villalón, A Morán Vascular Pharmacology 63 (1), 4-12, 2014 | 15 | 2014 |
| The role of endothelium-derived hyperpolarizing factor and cyclooxygenase pathways in the inhibitory serotonergic response to the pressor effect elicited by sympathetic … JÁ García-Pedraza, M García, ML Martín, L San Román, A Morán European journal of pharmacology 731, 80-87, 2014 | 15 | 2014 |
| 5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats JÁ García-Pedraza, M García, ML Martín, A Morán Vascular Pharmacology 72, 172-180, 2015 | 13 | 2015 |
| Chronic 5-HT2 receptor blockade unmasks the role of 5-HT1F receptors in the inhibition of rat cardioaccelerator sympathetic outflow JÁ García-Pedraza, O Hernández-Abreu, M García, A Morán, CM Villalón Canadian journal of physiology and pharmacology 96 (4), 328-336, 2018 | 12 | 2018 |
| Chronic sarpogrelate treatment reveals 5-HT7 receptor in the serotonergic inhibition of the rat vagal bradycardia JÁ García-Pedraza, M García, ML Martín, N Eleno, A Morán Journal of Cardiovascular Pharmacology 69 (1), 13-22, 2017 | 10 | 2017 |
| 5‐HT modulates the rat mesenteric vasopressor outflow by 5‐HT1D sympatholytic receptors JÁ García‐Pedraza, M García‐Domingo, M Gómez‐Roso, ... Clinical and Experimental Pharmacology and Physiology 44 (12), 1224-1231, 2017 | 9 | 2017 |
| Vascular sympathetic neurotransmission and its serotonergic regulation are modified by chronic fluoxetine treatment JÁ García-Pedraza, C Lopez, JF Fernández-González, ML Martín, ... Journal of Pharmacological Sciences 147 (1), 48-57, 2021 | 7 | 2021 |
| Role of peripheral 5-HT5A receptors in 5-HT-induced cardiac sympatho-inhibition in type 1 diabetic rats JÁ García-Pedraza, O Hernández-Abreu, A Morán, J Carretero, ... Scientific Reports 10 (1), 19358, 2020 | 7 | 2020 |
| 5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature JA García-Pedraza, M García, ML Martín, A Rodríguez-Barbero, A Morán Vascular Pharmacology 79, 51-59, 2016 | 7 | 2016 |
| Hypertension exhibits 5-HT4 receptor as a modulator of sympathetic neurotransmission in the rat mesenteric vasculature JÁ García-Pedraza, M García-Domingo, M Gómez-Roso, ... Hypertension Research 42 (5), 618-627, 2019 | 6 | 2019 |
| Fluoxetine oral treatment discloses 5-HT1D receptor as vagoinhibitor of the cardiac cholinergic neurotransmission in rat C López, M Gómez-Roso, JÁ García-Pedraza, ML Martín, A Morán, ... Canadian Journal of Physiology and Pharmacology 97 (2), 90-98, 2019 | 6 | 2019 |
| Blocking 5-HT2 receptor restores cardiovascular disorders in type 1 experimental diabetes JÁ García-Pedraza, P Ferreira-Santos, R Aparicio, MJ Montero, A Morán Scientific Reports 6 (1), 33979, 2016 | 6 | 2016 |
| Oral fluoxetine treatment changes serotonergic sympatho-regulation in experimental type 1 diabetes JÁ García-Pedraza, JF Fernández-González, C López, ML Martín, ... Life Sciences 293, 120335, 2022 | 5 | 2022 |
| Dopamine D4 receptor subtype activation reduces the rat cardiac parasympathetic discharge JÁ García-Pedraza, A Morán, ML Martín, C Ollauri-Ibáñez, ... Pflügers Archiv-European Journal of Physiology 472, 1693-1703, 2020 | 5 | 2020 |
| Pharmacological evidence that 5‐HT1D activation induces renal vasodilation by NO pathway in rats JÁ García‐Pedraza, M García, ML Martín, A Morán Clinical and Experimental Pharmacology and Physiology 42 (6), 640-647, 2015 | 5 | 2015 |
| Effect of sarpogrelate treatment on 5-HT modulation of vascular sympathetic innervation and platelet activity in diabetic rats JF Fernández-González, JÁ García-Pedraza, A Marín-Quílez, JM Bastida, ... Biomedicine & Pharmacotherapy 153, 113276, 2022 | 3 | 2022 |
| Pharmacological Evidence that Histamine H3 Receptors Mediate Histamine‐Induced Inhibition of the Vagal Bradycardic Out‐flow in Pithed Rats M García, JÁ García‐Pedraza, CM Villalón, A Morán Basic & Clinical Pharmacology & Toxicology 118 (2), 113-121, 2016 | 3 | 2016 |
| Blockade of 5‐HT2 receptors with sarpogrelate uncovers 5‐HT7 receptors inhibiting the tachycardic sympathetic drive in pithed rats OI Hernández‐Abreu, JÁ García‐Pedraza, E Rivera‐Mancilla, ... Clinical and Experimental Pharmacology and Physiology 47 (3), 403-411, 2020 | 2 | 2020 |
| Fluoxetine Treatment Decreases Cardiac Vagal Input and Alters the Serotonergic Modulation of the Parasympathetic Outflow in Diabetic Rats M García-Domingo, JÁ García-Pedraza, JF Fernández-González, ... International Journal of Molecular Sciences 23 (10), 5736, 2022 | 1 | 2022 |
